PMID: 2506157Sep 1, 1989Paper

Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy

International Journal of Radiation Oncology, Biology, Physics
S M BentzenH D Thames

Abstract

A clinical radiobiological study of the fractionation sensitivity of impaired shoulder movement after postmastectomy radiotherapy is presented. From 1978 to 1980, 163 breast cancer patients received postmastectomy irradiation delivered in 12 fractions, 2 fractions per week, over a period of 37 to 46 days. The total dose was specified either as a maximum absorbed dose of 51.36 Gy, or as a minimum target dose of 36.6 Gy specified at the level of midaxilla. From 1981 to 1982, 66 patients received a minimum target dose of 40.92 Gy in 22 fractions with 5 fractions per week over a period of 29 to 35 days. The treatment technique remained essentially unchanged during the whole period of 1978 to 1982. Maximal flexion and abduction of the arm were measured with unfixed scapula. A relative score, indicating the grade of impaired shoulder movement on a nominal scale from 0-3, was established by comparison with the mobility of the contralateral arm. In addition, working ability and pain at movement and at rest were evaluated. These performance parameters significantly correlated with the grade of impaired shoulder movement. The occurrence of moderately or severely impaired shoulder movement was analyzed using a mixture model incorporating ...Continue Reading

Associated Clinical Trials

References

May 1, 1977·International Journal of Radiation Oncology, Biology, Physics·L Cohen, S E Ubaldi
Jan 1, 1989·International Journal of Radiation Biology·S M BentzenD O Dixon
Jul 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S M BentzenM Overgaard
Apr 1, 1986·International Journal of Radiation Oncology, Biology, Physics·I Turesson, G Notter
Jun 1, 1986·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·H D ThamesE L Travis
Jun 1, 1985·International Journal of Radiation Oncology, Biology, Physics·M Overgaard
Feb 1, 1983·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher
Jul 1, 1983·The British Journal of Radiology·J F Fowler
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher

❮ Previous
Next ❯

Citations

Nov 26, 2008·Breast Cancer Research and Treatment·Pamela K Levangie, Jacqueline Drouin
Dec 30, 2008·Breast Cancer Research and Treatment·Inger-Lise NesvoldAlv A Dahl
Oct 26, 2010·Journal of Cancer Survivorship : Research and Practice·Inger-Lise NesvoldAlv A Dahl
Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·E L GilletteZ Vujaskovic
Jul 13, 2000·International Journal of Radiation Oncology, Biology, Physics·J MarinusL H Beukema
Jan 5, 2002·International Journal of Radiation Oncology, Biology, Physics·Akmal SafwatJolyon H Hendry
Dec 1, 1996·International Journal of Radiation Oncology, Biology, Physics·I TuressonA Odén
Mar 8, 2000·International Journal of Radiation Oncology, Biology, Physics·A TakedaA Kubo
Mar 13, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Overgaard
Aug 7, 2003·Seminars in Radiation Oncology·Aileen M DavisBrian O'Sullivan
Aug 7, 2003·Seminars in Radiation Oncology·Brian O'Sullivan, Wilfred Levin
Jan 6, 2006·The Cancer Journal·Loren K Mell, Arno J Mundt
Mar 17, 2007·International Journal of Clinical Practice·L B GomideF J Candido dos Reis
Jan 25, 2013·World Journal of Gastroenterology : WJG·Abobakr K ShadadLaurence J Egan
Apr 18, 2002·International Journal of Radiation Oncology, Biology, Physics·Saeko HirotaMitsuyuki Abe
Jan 16, 2007·Breast Cancer Research and Treatment·Carmen LillaJenny Chang-Claude
Feb 6, 2014·Acta Oncologica·Safora JohansenSophie D Fosså
Jul 6, 2010·Biochemical Pharmacology·Amit Deorukhkar, Sunil Krishnan
Jul 1, 1991·International Journal of Radiation Oncology, Biology, Physics·S H Levitt, G H Fletcher
Mar 3, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·A MunshiK A Dinshaw
Mar 8, 2016·International Journal of Environmental Research and Public Health·Gholamreza OskrochiDelva Shamley
Sep 1, 2004·International Journal of Radiation Oncology, Biology, Physics·Aileen M DavisRobert S Bell
Nov 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·H D ThamesW Van den Bogaert
May 10, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·John M Kurtz
Mar 31, 2015·International Journal of Radiation Oncology, Biology, Physics·Xiaofeng YangTian Liu
Oct 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Winkle KwanIvo A Olivotto
Jul 29, 2003·Journal of Surgical Oncology·Rik GosselinkMarie-Rose Christiaens
Aug 1, 1995·The European Journal of Neuroscience·J GrenhoffS W Johnson
Jan 1, 1993·Acta Oncologica·S M Bentzen
Jan 1, 1995·Acta Oncologica·T Landberg
Apr 15, 2020·Acta Oncologica·Katrine Rye HauerslevPeer Christiansen
Mar 27, 1999·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·H GeinitzM Molls
Mar 11, 2019·Breast Cancer Research and Treatment·Elizabeth A ChrischillesIngrid M Lizarraga
Jan 1, 1990·International Journal of Radiation Biology·S M BentzenC Smith
Nov 13, 2020·Journal of Plastic Surgery and Hand Surgery·Hans P GullestadSophie D Fosså
May 29, 2021·International Journal of Radiation Oncology, Biology, Physics·Robert W MutterShannon M MacDonald

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved